Washington June 10 (ANI): Liver transplantation is the mainstay of treatment for patients with end-stage liver disease but a new research from the Icahn School of Medicine at Mount Sinai has suggested that it may one day become possible to regenerate a liver using cell therapy in patients with liver disease. Investigators discovered that a human embryonic stem cell can be differentiated into a previously unknown liver progenitor cell an early offspring of a stem cell and produce mature and functional liver cells. ‘The discovery of the novel progenitor represents a fundamental advance in this field and potentially to the